AstraZeneca: Vaxzevria as booster can increase antibody levels against Omicron
- Current Drug Therapies for Non-Small Cell Lung Cancer
- Harvard study: studied healthy eating can prolong life and reduce risks of death!
- Massachusetts: Prisoners may get a reduced sentence by donating organs
- Smoking seriously hurts human brains
- Why are vegetarians more likely to suffer from depression than meat eaters?
- Small wireless device implanted between skin and skull helps kill cancer cells
AstraZeneca: Vaxzevria as booster can increase antibody levels against Omicron
- First human trial of HIV gene therapy: A one-time cure will be achieved if successful!
- New breakthrough in CAR-T cell therapy: Lupus erythematosus patients achieved treatment-free remission for up to 17 months
- How long can the patient live after heart stent surgery?
- First time: Systemic multi-organ recovery after death
- Where do the bacteria in the human gut come from?
AstraZeneca: Latest data show Vaxzevria as booster can increase antibody levels against Omicron.
AstraZeneca (AZN.US) said on Thursday that its latest preliminary data from its COVID-19 vaccine Vaxzevria showed significant antibody levels to Omicron and other variants, including Beta, Delta, Alpha and Gamma when Vaxzevria was given as a third booster dose Increase.
AstraZeneca said the booster shot boosted antibody responses in people previously vaccinated with Vaxzevria or the mRNA vaccine.
The company added that, given the urgent need for booster shot, the company will submit this data to global regulators.
Andrew Pollard, director of the Oxford Vaccine Group, said in a statement: “These important studies show that a third dose of Vaxzevria can significantly boost immunity to Covid-19 following two doses of the vaccine, or following mRNA or inactivated vaccines. “
It is understood that Vaxzevria, which was co-developed by researchers at AstraZeneca and the University of Oxford, was found to be effective against the Omicron variant by three doses of Vaxzevria in a laboratory study last month.
Separately, in December, a large UK trial found that AstraZeneca’s booster shot increased antibody levels in people vaccinated with AstraZeneca’s vaccine or Pfizer’s (PFE.US) vaccine.
Still, the study concluded that the Pfizer and Moderna (MRNA.US) vaccines work best as boosters.
AstraZeneca: Vaxzevria as booster can increase antibody levels against Omicron
(source:internet, reference only)
Disclaimer of medicaltrend.org